Atención al cliente y seguridad de la cadena de suministro en 2021 - Rajesh Sadanandan habla en CPhI Pharma Trends 2021
26 de noviembre de 2020
Rajesh Sadanandan, Director de Ventas de IFA para Estados Unidos y Europa, en Dr Reddy’s Laboratories, comparte su perspectiva acerca de la necesidad de la industria farmacéutica de permanecer centrado en el paciente y ejercer los planes de seguridad de la cadena de suministro en 2021.
Descargue el informe aquí y lea más acerca del tema..
+91 4049002253 Descargo de responsabilidad
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.